Statement Of Changes In Equity [Abstract]

Bayer AG - Filing #6464694

Concept 2024-01-01 to
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
As at
2024-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
Statement of changes in equity [abstract]
Statement of changes in equity [line items]
Equity
16,000,000 EUR
9,867,000 EUR
18,261,000 EUR
2,515,000 EUR
137,000,000 EUR
1,257,000 EUR
31,908,000 EUR
8,000,000 EUR
32,045,000 EUR
33,078,000 EUR
12,175,000 EUR
81,000,000 EUR
151,000,000 EUR
18,261,000 EUR
2,515,000 EUR
128,000,000 EUR
32,927,000 EUR
23,000,000 EUR
38,926,000 EUR
112,000,000 EUR
153,000,000 EUR
18,261,000 EUR
17,233,000 EUR
2,515,000 EUR
531,000,000 EUR
38,773,000 EUR
121,000,000 EUR
Changes in equity [abstract]
Comprehensive income [abstract]
Profit (loss)
2,552,000 EUR
2,552,000 EUR
6,000,000 EUR
2,546,000 EUR
2,942,000 EUR
2,941,000 EUR
1,000,000 EUR
2,941,000 EUR
Other comprehensive income
1,594,000 EUR
75,000,000 EUR
1,385,000 EUR
370,000,000 EUR
3,000,000 EUR
1,597,000 EUR
86,000,000 EUR
485,000,000 EUR
483,000,000 EUR
27,000,000 EUR
2,000,000 EUR
326,000,000 EUR
659,000,000 EUR
123,000,000 EUR
Comprehensive income
949,000,000 EUR
3,427,000 EUR
Dividends recognised as distributions to owners
108,000,000 EUR
108,000,000 EUR
23,000,000 EUR
131,000,000 EUR
2,379,000 EUR
2,358,000 EUR
21,000,000 EUR
2,358,000 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.